Summary
A Review of ninety seven patients with Hodgkin’s disease treated with chemotherapy at a single institution is reported. Fifty were male and forty seven female. The mean age at diagnosis was 32.9 years (range : 11–79 years).
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Bergsagel, D. E., Alison, R. E., Bean, H. A., Brown, T. C., Bush, R. S., Clarke, R. M.et al. 7 others). 1982. Results of treating Hodgkin’s disease without a policy of laparotomy staging. Cancer Treat. Rep. 66, 717–731.
Bonadonna, G., Viviani, S., Bonfante, V., Valgussa, P., Santoro, A. 1984. Alternating chemotherapy with MOPP/ABVD in Hodgkin’s disease: update results. Proceedings of the American Society of Clinical Oncology. 3, 254.
Carter, S. K. and Livingstone, R. B. 1973. Single-agent therapy for Hodgkin’s disease. Arch. Intern. Med. 131, 377–387.
Coltman, C. A. and Dixon, D. O. 1982. Second malignancies complicating Hodgkin’s disease: A South-West oncology group ten year follow up. Cancer Treat. Rep. 66, 1023.
Cunningham, J., Mauch, P., Rosenthal, D. S., Canellos, G. P. 1982. Longterm complications of MOPP chemotherapy in patients with Hodgkin’s disease. Cancer Treat. Rep. 66, 1015–1022.
De Vita, V. T. (Jr.), Serpick, A., Carbone, P. P. 1970. Combination chemotherapy in the treatment of advanced Hodgkin’s disease. Ann. Intern. Med. 73, 881.
Goldsmith, M. A. and Carter, S. K. 1974. Combination chemotherapy of advanced Hodgkin’s disease—a review. Cancer 33, 1–7.
Haybittle, J. L., Easterling, M. J., Bennett, M. H.et al. 1985. Review of British National Lymphoma Investigation Studies of Hodgkin’s disease and development of prognostic index. Lancet i, 967–972.
Hoppe, R. T., Portlock, C. S., Glatstein, E., Rosenberg, S. A., Kaplan, H. S. 1979. Alternating chemotherapy and irradiation in the treatment of advanced Hodgkin’s disease. Cancer 43, 472.
Kaye, S. B., Juttner, C. A., Smith, I. E., Barrett, A., Austin, D. F., Peckham, M. J., McElwain, T. J. 1979. Three years experience with ChlVPP (A combination of drugs with low toxicity) for the treatment of Hodgkin’s disease. Br. J. Cancer 39, 168–174.
Larson, R. A. and Ulmann, J. E. 1982. The strategic role of laparotomy in staging Hodgkin’s disease. Cancer Treat. Rep. 66, 727–734.
Lee, D., Anderson, J. R., Stirling, M. L., French, M., Naysmith, A. 1981. The value of staging laparotomy in Hodgkin’s disease—three years experience of the Edinburgh Lymphoma Group. Clin. Oncol. 7, 105–114.
Lister, T. A. 1985. Hodgkin’s disease in adults: The challenge. Postgrad. Med. J. 61, 103–107.
Lukes, R. J. and Butler, J. J. 1966. The pathology and nomenclature of Hodgkin’s disease. Cancer Res. 36, 1310.
McElwain, T. J. 1983. Solid tumours of the lymphoid system. Medicine International. 1 (26), 1218–1224.
McVie, J. G. and Somers, R. 1985. Chemotherapy of Hodgkin’s disease comes of age. Br. Med. J. 290, 950–951.
Moore, M. R., Bull, J. M., Jones, S. E., Rosenberg, S. A., Kaplan, H. S. 1972. Sequential radiotherapy and chemotherapy in the treatment of Hodgkin’s disease; a progress report. Ann. Intern. Med. 77, 1.
Nixon, D. W. and Aisenberg, A. C. 1974. Combination chemotherapy of Hodgkin’s disease. Cancer 33, 1499–1504.
Peto, R., Pike, M. C., Armitage, P., and seven others. 1976/1977. Design and analysis of randomized clinical trials requiring prolonged observation of each patient. Br. J. Cancer 34, 583–612 and 35, 1-39.
Powderly, W. G., Cantwell, B. M., Fennelly, J. J., Warde, P., McCabe, M. M., Towers, R. P. 1985. Renal glomerulopathies associated with Hodgkin’s disease. Cancer 56(4), 874–875.
Prosnitz, L. R., Farber, L. R., Fischer, J. J., Bertino, J. R., Fisher, D. B. 1976. Long-term remissions with combined modality therapy for advanced Hodgkin’s disease. Cancer 37, 2826.
Rosenberg, S. A., Kaplan, H. S., Glatstein, E. J., Portlock, C. S. 1978. Combined modality therapy in Hodgkin’s disease. A report on the Stanford trials. Cancer 42, 991.
Santoro, A. and Bonadonna, G. 1979. Prolonged disease-free survival in MOPP-resistant Hodgkin’s disease after treatment with Adriamycin, Bleomycin, Vinblastine and Decarbazine [ABVD]. Cancer Chemother. Pharmacol. 2, 101–105.
Suthcliffe, S. B., Wrigley, P. F. M., Peto, J. (and five others). 1978. MVPP chemotherapy regimen for advanced Hodgkin’s disease. Br. Med. J. 1, 679.
Symposium on Staging in Hodgkin’s disease. Ann. Arbor, Mich. 1971. Cancer Res. 1, 31.
Tubiana, M., Henry-Amar, M., Hayat, M.et al. 1985. Prognostic factors in Hodgkin’s disease. Lancet ii, 165.
Van Dongen, J. A., Somers, R., Burgers, J. M. V., Hart, A. A. M. 1979. Staging laparotomies in Hodgkin’s disease and non-Hodgkin’s Lymphoma: Changing ideas on indications. Clin. Oncol. 5, 201–208.
Waxman, J. H., Terry, Y. A., Wrigley, P. F. M., Malpas, J. S., Rees, L. H., Besser, G. M., Lister, T. A. 1982. Gonadal function in Hodgkins disease; long-term follow-up of chemotherapy. Br. Med. J. 285, 1612.
Waxman, J. 1985. Cancer, chemotherapy and fertility. Br. Med. J. 290, 1096–1097.
Author information
Authors and Affiliations
Additional information
The authors sincerely acknowledge the help of Dr. B. Hourihane, Dr. M. Moriarty and Dr. S. Cahalane in the management of the patients included in this study. We are also grateful to Dr. B. Cantwell for his invaluable advice and support.
Rights and permissions
About this article
Cite this article
Bourke, J.P., Fennelly, J.J., Duggan, J. et al. Chemotherapy treated hodgkins disease — A fifteen year review. I.J.M.S. 155, 300–307 (1986). https://doi.org/10.1007/BF02960708
Issue Date:
DOI: https://doi.org/10.1007/BF02960708